Flexion Therapeutics, Inc.
FLXN
FLXN was delisted on the 18th of November, 2021.
139 hedge funds and large institutions have $892M invested in Flexion Therapeutics, Inc. in 2017 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 68 increasing their positions, 23 reducing their positions, and 14 closing their positions.
196% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 23
164% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 14
35% more capital invested
Capital invested by funds: $660M → $892M (+$232M)
20% more funds holding
Funds holding: 116 → 139 (+23)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less call options, than puts
Call options by funds: $18.8M | Put options by funds: $20.4M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$38.1M |
| 2 |
MVP
Miller Value Partners
Sarasota,
Florida
|
+$36.8M |
| 3 |
State Street
Boston,
Massachusetts
|
+$30.9M |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$23.8M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$13.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$36.3M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$8.25M |
| 3 |
NC
Nexthera Capital
New York
|
-$6.64M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$5.95M |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$5.19M |
FLXN Hedge Fund Activity: Q4 2017 in Review
139 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Flexion Therapeutics, Inc. (FLXN) for Q4 2017, worth a combined $892M — up 35% from $660M a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new FLXN positions and 14 closed out — a net gain of 23 holders — while 68 added to existing stakes and 23 trimmed.
The largest buyer was Wells Fargo, adding an estimated $38.1M. The largest seller was Novo Holdings A/S, exiting entirely with an estimated $36.3M sold.
- 139 institutional investors held Flexion Therapeutics, Inc. (FLXN) as of Q4 2017, up from 116 in Q3 2017.
- Funds reported $892M of Flexion Therapeutics, Inc. stock for Q4 2017, up 35% quarter-over-quarter.
- 37 funds opened new Flexion Therapeutics, Inc. positions in Q4 2017 and 14 closed out, a net change of +23 holders.
- The largest Flexion Therapeutics, Inc. buyer in Q4 2017 was Wells Fargo, an estimated $38.1M added.
- The largest Flexion Therapeutics, Inc. seller in Q4 2017 was Novo Holdings A/S, an estimated $36.3M sold.
Based on aggregated 13F filings for Q4 2017.